Evidence map›Paper›PMID 42437258›Full record

ArticleCureus2026

Dermatomyositis With Necrotizing Vasculitis, Pulmonary Arterial Hypertension, and Extensive Calcinosis Following Delayed Diagnosis.

Amine Laabichi, Wafa Ammouri, Naima Mouatassim, Mouna Maamar, Hicham Harmouche

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amine LaabichiInternal Medicine and Clinical Immunology, Centre Hospitalier Universitaire Ibn Sina, Rabat, MAR.
Wafa AmmouriInternal Medicine and Clinical Immunology, Centre Hospitalier Universitaire Ibn Sina, Rabat, MAR.
Naima MouatassimInternal Medicine and Clinical Immunology, Centre Hospitalier Universitaire Ibn Sina, Rabat, MAR.
Mouna MaamarAcute Geriatrics Unit, Internal Medicine and Clinical Immunology, Centre Hospitalier Universitaire Ibn Sina, Rabat, MAR.
Hicham HarmoucheInternal Medicine and Clinical Immunology, Centre Hospitalier Universitaire Ibn Sina, Rabat, MAR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dermatomyositis is a rare autoimmune inflammatory disease with a highly heterogeneous clinical presentation and potential for multisystem involvement. Early diagnosis may be challenging, particularly in patients presenting with amyopathic disease and limited initial laboratory abnormalities. We report the case of a 45-year-old woman initially diagnosed with amyopathic dermatomyositis based on characteristic cutaneous manifestations in the absence of objective muscle involvement on laboratory testing and electromyography. After being lost to follow-up for four years, she presented with progressive proximal muscle weakness, extensive ulcerative calcinosis, Raynaud phenomenon, and exertional dyspnea. Extended myositis serology revealed anti-Mi-2 and anti-signal recognition particle (SRP) antibodies. Muscle biopsy demonstrated perifascicular atrophy, necrotizing vasculitis, and foreign-body granulomatous inflammation associated with dystrophic calcinosis. Right heart catheterization confirmed pre-capillary pulmonary arterial hypertension in the absence of interstitial lung disease. The patient was treated with intravenous cyclophosphamide, pulmonary vasodilator therapy, colchicine, and tapering corticosteroids, resulting in clinical and functional improvement. This case highlights the potential progression of initially amyopathic dermatomyositis to severe systemic disease, the limitations of isolated serological assessment, and the importance of long-term follow-up. It also illustrates several uncommon manifestations of adult dermatomyositis, including extensive calcinosis, pulmonary arterial hypertension, and histologically proven necrotizing vasculitis, supporting the concept of dermatomyositis as a systemic vasculopathic disorder.

Indexed as

autoantibodiescalcinosisinflammatory myopathypulmonary arterial hypertensions: dermatomyositisvasculitis

Identifiers

PMID42437258
PMCPMC13355916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.